Waverley Pharma was founded in 2014 and became a public company in October 2017. The company trades under the symbol WAVE on the TSX Venture Exchange. As an oncology focused pharma company, Waverley Pharma carefully monitors opportunities and possible acquisitions of related pharmaceutical products in order to realize long term value.
Click below to check our corporate presentation.
Click below to check our financial reports.
For MD&As and other documents,
click here
